Lam Research Operating Cash Flow decreased by 30.4% to $1.78B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.4%, from $1.57B to $1.78B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 14.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.44B | $457.52M | $1.87B | $325.97M | $443.93M | $1.19B | $1.22B | $1.65B | $1.12B | $951.16M | $1.36B | $1.48B | $862.43M | $1.57B | $1.69B | $360.07M | $2.55B | $1.78B |
| QoQ Change | — | -68.1% | +309.2% | -82.6% | +36.2% | +168.0% | +2.2% | +35.9% | -32.0% | -15.3% | +42.9% | +8.8% | -41.7% | +81.9% | +7.8% | -78.7% | +609.4% | -30.4% |
| YoY Change | — | — | — | — | -69.1% | +160.0% | -35.1% | +406.6% | +152.9% | -20.0% | +11.8% | -10.4% | -23.2% | +64.9% | +24.4% | -75.7% | +196.2% | +13.4% |